Search company, investor...

Compare Soleno Therapeutics vs Metabolic Solutions Development

Customers evaluate the quality of Soleno Therapeutics's products using the following success metrics.

Overview

Soleno Therapeutics is based in United States

Soleno Therapeutics (Soleno) is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company is advancing its lead candidate, DCCR, a once-daily, oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017. PWS is a rare and complex, genetic, neurobehavioral/metabolic disorder affecting appetite, growth, metabolism, cognitive function, and behavior. DCCR has received Orphan Drug Designation from the US FDA for the treatment of PWS. Diazoxide choline controlled-release tablet is a proprietary controlled-release, crystalline salt formulation of diazoxide, which is administered once-daily. In the PWS pilot study, DCCR showed promise in addressing the hallmark symptoms of PWS, most notably hyperphagia. Soleno, through its wholly owned subsidiary, Capnia, continues to market Capnia's medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns.

Metabolic Solutions Development is 18 yrs old and is based in United States.

Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.

Demo Video

Demo not available because Soleno Therapeutics has not claimed their profile.

Work for Soleno Therapeutics? Show off your product.

Demo not available because Metabolic Solutions Development has not claimed their profile.

Work for Metabolic Solutions Development? Show off your product.

Funding

Soleno Therapeutics last raised $16.5M on 12/19/2018.
Metabolic Solutions Development last raised $200K on 2/6/2019.

Investors

SWMF Life Science Fund, Hopen Life Sciences Ventures

See all 3 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Soleno Therapeutics has not claimed their profile.

Work for Soleno Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Soleno Therapeutics?

Claim your profile now.

Information not available because Metabolic Solutions Development has not claimed their profile.

Work for Metabolic Solutions Development? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Metabolic Solutions Development?

Claim your profile now.